Peripheral Artery Disease (PAD) Clinical Trial
Official title:
Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent
The purpose of this post-authorization registry is to describe the clinical outcomes of de novo and restenotic lesions in the superficial femoral and/or popliteal artery treated with the PULSAR® -18 T3 stent, implanted both primary and salvage.
Post-authorization, prospective and multicenter registry to evaluate the clinical results of the PULSAR® -18 T3 stent, in the treatment of de novo or restenotic lesions of the superficial femoral and/or popliteal artery, primarily as salvage, in a population of patients residing in Spain and in "real life" conditions. In this registry, data will be collected from approximately 100 consecutive patients who have been treated with the PULSAR® -18 T3 Stent. Subjects with PAD treated with the PULSAR® -18 T3 Stent will be assessed for eligibility for the registry and will be consecutively included in the registry. Once informed consent is obtained, the required data will be collected. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02227368 -
Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
|
Phase 2 | |
Completed |
NCT03744572 -
Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical Investigation in Infrapopliteal Interventions
|
||
Active, not recruiting |
NCT06052319 -
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
|
||
Recruiting |
NCT05941533 -
Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease
|
||
Active, not recruiting |
NCT02924857 -
The Chocolate Touch Study
|
N/A | |
Active, not recruiting |
NCT04821388 -
Α Pre CE-Marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal Arteries
|
N/A | |
Recruiting |
NCT03304821 -
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
|
Phase 2 | |
Completed |
NCT02220686 -
Vascular Physician Offer and Report (VAPOR) Trial
|
N/A |